Please use this identifier to cite or link to this item:
DC FieldValue
dc.titleA Novel HNF4A Mutation Causing Three Phenotypic Forms of Glucose Dysregulation in a Family
dc.contributor.authorChandran, S.
dc.contributor.authorRajadurai, V.S.
dc.contributor.authorHoi, W.H.
dc.contributor.authorFlanagan, S.E.
dc.contributor.authorHussain, K.
dc.contributor.authorYap, F.
dc.identifier.citationChandran, S., Rajadurai, V.S., Hoi, W.H., Flanagan, S.E., Hussain, K., Yap, F. (2020). A Novel HNF4A Mutation Causing Three Phenotypic Forms of Glucose Dysregulation in a Family. Frontiers in Pediatrics 8 : 320. ScholarBank@NUS Repository.
dc.description.abstractMaturity-onset diabetes of the young (MODY) classically describes dominantly inherited forms of monogenic diabetes diagnosed before 25 years of age due to pancreatic ?-cell dysfunction. In contrast, mutations in certain MODY genes can also present with transient or persistent hyperinsulinemic hypoglycemia in newborn infants, reflecting instead ?-cell dysregulation. Of the MODY genes described to date, only hepatocyte nuclear factor-4-alpha (HNF4A; MODY1) and hepatocyte nuclear factor-1-alpha (HNF1A; MODY3) mutations may result in a biphasic phenotype of hypoglycemia in early life and hyperglycemia in later life. We report a family with a novel HNF4A mutation with diverse phenotypic presentations of glucose dysregulation. The proband was a term, appropriate-for-gestational age male infant with symptomatic hypoglycemia on day 3 of life needing high glucose infusion rate to maintain normoglycemia. He was born to a non-obese and non-diabetic mother. Glucose regulation was optimized using diazoxide upon confirmation of hyperinsulinism. Cascade genetic screening identified the same mutation in his father and elder sister, but mother was negative. Father was diagnosed with Type 1 diabetes at 15 years of age that required insulin therapy. Proband's elder sister, born at term appropriate for gestational age, presented with transient neonatal hypoglycemia needing parenteral glucose infusion for a week followed by spontaneous resolution. The paternal grandparents were negative for this mutation, confirming a paternal de novo mutation and autosomal dominant inheritance in this family. This pedigree suggests that the presence of early-onset paternal diabetes should prompt molecular testing in infants presenting in the newborn period with diazoxide-responsive hyperinsulinemic hypoglycemia, even in the absence of maternal diabetes and macrosomia. � Copyright � 2020 Chandran, Rajadurai, Hoi, Flanagan, Hussain and Yap.
dc.publisherFrontiers Media S.A.
dc.rightsAttribution 4.0 International
dc.sourceScopus OA2020
dc.subjectcongenital hyperinsulinism
dc.subjecthepatocyte nuclear factor 4-alpha
dc.subjecthepatocyte nuclear factor?1- alpha
dc.subjecthyperinsulinemic hypoglycemia of infancy
dc.subjectmaturity-onset diabetes mellitus
dc.contributor.departmentDUKE-NUS MEDICAL SCHOOL
dc.description.sourcetitleFrontiers in Pediatrics
Appears in Collections:Elements
Staff Publications

Show simple item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
10_3389_fped_2020_00320.pdf860.87 kBAdobe PDF




checked on Jun 22, 2022


checked on Oct 5, 2021

Page view(s)

checked on Jun 23, 2022

Google ScholarTM



This item is licensed under a Creative Commons License Creative Commons